These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 17605005

  • 61. Effects of ecstasy/polydrug use on memory for associative information.
    Gallagher DT, Fisk JE, Montgomery C, Judge J, Robinson SJ, Taylor PJ.
    Psychopharmacology (Berl); 2012 Aug; 222(4):579-91. PubMed ID: 22302139
    [Abstract] [Full Text] [Related]

  • 62. The neuropsychology of ecstasy (MDMA) use: a quantitative review.
    Zakzanis KK, Campbell Z, Jovanovski D.
    Hum Psychopharmacol; 2007 Oct; 22(7):427-35. PubMed ID: 17896346
    [Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64. Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls.
    Morgan CJ, Muetzelfeldt L, Curran HV.
    Addiction; 2009 Jan; 104(1):77-87. PubMed ID: 19133891
    [Abstract] [Full Text] [Related]

  • 65. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
    Quednow BB, Jessen F, Kuhn KU, Maier W, Daum I, Wagner M.
    J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711
    [Abstract] [Full Text] [Related]

  • 66. Electrophysiological indices of response inhibition in human polydrug users.
    Roberts CA, Fairclough S, Fisk JE, Tames FT, Montgomery C.
    J Psychopharmacol; 2013 Sep; 27(9):779-89. PubMed ID: 23803689
    [Abstract] [Full Text] [Related]

  • 67. Dysfunctional overnight memory consolidation in ecstasy users.
    Smithies V, Broadbear J, Verdejo-Garcia A, Conduit R.
    J Psychopharmacol; 2014 Aug; 28(8):751-62. PubMed ID: 24595967
    [Abstract] [Full Text] [Related]

  • 68. ERP evidence suggests executive dysfunction in ecstasy polydrug users.
    Roberts CA, Fairclough SH, Fisk JE, Tames F, Montgomery C.
    Psychopharmacology (Berl); 2013 Aug; 228(3):375-88. PubMed ID: 23532375
    [Abstract] [Full Text] [Related]

  • 69. MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users.
    Parrott AC.
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1466-84. PubMed ID: 23660456
    [Abstract] [Full Text] [Related]

  • 70. Visuo-spatial working memory deficits in current and former users of MDMA ('ecstasy').
    Wareing M, Fisk JE, Murphy P, Montgomery C.
    Hum Psychopharmacol; 2005 Mar; 20(2):115-23. PubMed ID: 15641126
    [Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
    Soar K, Parrott A, Turner J.
    J Psychopharmacol; 2009 Sep; 23(7):745-58. PubMed ID: 18635698
    [Abstract] [Full Text] [Related]

  • 73. Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users.
    Daumann J, Fischermann T, Heekeren K, Henke K, Thron A, Gouzoulis-Mayfrank E.
    Psychopharmacology (Berl); 2005 Aug; 180(4):607-11. PubMed ID: 15372137
    [Abstract] [Full Text] [Related]

  • 74. Apparent transient effects of recent "ecstasy" use on cognitive performance and extrapyramidal signs in human subjects.
    Smith RM, Tivarus M, Campbell HL, Hillier A, Beversdorf DQ.
    Cogn Behav Neurol; 2006 Sep; 19(3):157-64. PubMed ID: 16957494
    [Abstract] [Full Text] [Related]

  • 75. Patterns of memory dysfunction in current and 2-year abstinent MDMA users.
    Ward J, Hall K, Haslam C.
    J Clin Exp Neuropsychol; 2006 Apr; 28(3):306-24. PubMed ID: 16618622
    [Abstract] [Full Text] [Related]

  • 76. Working memory deficits in current and previous users of MDMA ('ecstasy').
    Wareing M, Fisk JE, Murphy PN.
    Br J Psychol; 2000 May; 91 ( Pt 2)():181-8. PubMed ID: 10832513
    [Abstract] [Full Text] [Related]

  • 77. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
    Indlekofer F, Piechatzek M, Daamen M, Glasmacher C, Lieb R, Pfister H, Tucha O, Lange KW, Wittchen HU, Schütz CG.
    J Psychopharmacol; 2009 Jul; 23(5):495-509. PubMed ID: 18635709
    [Abstract] [Full Text] [Related]

  • 78. MDMA and brain activity during neurocognitive performance: An overview of neuroimaging studies with abstinent 'Ecstasy' users.
    Roberts CA, Quednow BB, Montgomery C, Parrott AC.
    Neurosci Biobehav Rev; 2018 Jan; 84():470-482. PubMed ID: 28801175
    [Abstract] [Full Text] [Related]

  • 79. Residual effects of ecstasy (3,4-methylenedioxymethamphetamine) on low level visual processes.
    Murray E, Bruno R, Brown J.
    Hum Psychopharmacol; 2012 Mar; 27(2):226-34. PubMed ID: 22389087
    [Abstract] [Full Text] [Related]

  • 80. Incidental use of ecstasy: no evidence for harmful effects on cognitive brain function in a prospective fMRI study.
    Jager G, de Win MM, Vervaeke HK, Schilt T, Kahn RS, van den Brink W, van Ree JM, Ramsey NF.
    Psychopharmacology (Berl); 2007 Aug; 193(3):403-14. PubMed ID: 17476480
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.